(SizeLimitingPyMap: {associations={p_event_session_collection__event_session_to_speaker={items=[]}}, hs_object_id=4994317450, speaker_event_bio=Graduated in Political Sciences at International University “LUISS” of Rome, specialized in International Economics, I hold an MBA in International Business and Economics at Mib School of Management of Trieste. From march 2007 I joined Assogenerici (now EGUALIA), the Italian Generics and Biosimilars Medicines Association, as “Pharmaceutical Economics & Policy Affairs Manager”, assuming direct responsibility of the Centre for Economics and Policy Analysis of the association. Starting from March 2012 I have been appointed Director General of Assogenerici (now EGUALIA). Starting from 2016 I also have the responsibility as Director General of the IBG - Italian Biosimilars Group, the specialized body of Assogenerici (now EGUALIA) dedicated to biosimilars medicines. Member of the Executive Board of Medicines for Europe (European Generic & Biosimilars Medicines Industry Association), Chairman of the NAC (National Association Committee in Medicines for Europe) and member of various Medicines for Europe working groups., speaker_event_company=null, speaker_event_country=null, speaker_event_email=null, speaker_event_name={label=DEF VII, value=4840988957}, speaker_event_title=Director General, Egualia, Italy, speaker_first_name=Michele, speaker_last_name=Uda, speaker_name=Michele Uda | DEF VII, temp_speaker_event_photo=https://9293953.fs1.hubspotusercontent-na1.net/hubfs/9293953/Speakers/DEF%20VII/Michele%20Uda_.png})
Michele Uda
Director General, Egualia, Italy
Graduated in Political Sciences at International University “LUISS” of Rome, specialized in International Economics, I hold an MBA in International Business and Economics at Mib School of Management of Trieste. From march 2007 I joined Assogenerici (now EGUALIA), the Italian Generics and Biosimilars Medicines Association, as “Pharmaceutical Economics & Policy Affairs Manager”, assuming direct responsibility of the Centre for Economics and Policy Analysis of the association. Starting from March 2012 I have been appointed Director General of Assogenerici (now EGUALIA). Starting from 2016 I also have the responsibility as Director General of the IBG - Italian Biosimilars Group, the specialized body of Assogenerici (now EGUALIA) dedicated to biosimilars medicines. Member of the Executive Board of Medicines for Europe (European Generic & Biosimilars Medicines Industry Association), Chairman of the NAC (National Association Committee in Medicines for Europe) and member of various Medicines for Europe working groups.
